“Discontinuation Rate of Dual Antiretroviral Therapy With Dolutegravir Plus Lamivudine in People Living With HIV: A Systematic Review”. Research, Society and Development 11, no. 12 (September 19, 2022): e430111234758. Accessed December 15, 2025. https://www.rsdjournal.org/rsd/article/view/34758.